Literature DB >> 3818498

Comparison of the side effects and gastrointestinal motility observed after administration of erythromycin and josamycin to dogs.

X Y Qin, M A Pilot, H H Thompson, J P Maskell.   

Abstract

The effects of intravenous erythromycin and josamycin on gastrointestinal motility in dogs have been compared. Erythromycin interrupted the basal motility pattern in the fasted state and induced irregular bursts of spikes in both the fasted and fed states. Emesis occurred in all the dogs in the fasted state experiments and in four out of six dogs in the fed state experiments. Josamycin did not disturb gastrointestinal motility and no dog showed signs of discomfort. The difference in the chemical structure of erythromycin and josamycin is the main reason for their differential effect on the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3818498     DOI: 10.1093/jac/18.6.747

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Effects of two oral erythromycin ethylsuccinate formulations on the motility of the small intestine in human beings.

Authors:  F Caron; M Bouaniche; F Delatour; P Ducrotte; J C Torlotin; P Denis; G Humbert; B Rouveix
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

2.  Josamycin-induced pedal oedema.

Authors:  X Bosch; E Pedrol; X Casado; A Urbano-Marquez
Journal:  BMJ       Date:  1993-07-03

3.  Effect of spiramycin and tulathromycin on abomasal emptying rate in milk-fed calves.

Authors:  Mehdi Rashnavadi; Mohammad Nouri; Mohammad R Haji Hajikolaei; Housain Najafzadeh; Peter D Constable
Journal:  Can J Vet Res       Date:  2014-01       Impact factor: 1.310

Review 4.  Erythromycin and the gut.

Authors:  S M Catnach; P D Fairclough
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

5.  Effects of cholinoceptor and 5-hydroxytryptamine3 receptor antagonism on erythromycin-induced canine intestinal motility disruption and emesis.

Authors:  X Y Qin; M A Pilot; H Thompson; M Scott
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

Review 6.  Adverse effects of macrolide antibacterials.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

7.  Comparative in vitro activity of A-56268.

Authors:  A M Sefton; J P Maskell; F J Yong; S J Chi; J D Williams
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.